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The organic extract of the leaves of Schefflera umbellifera exhibited good antimalarial activity when tested against the chloroquine-susceptible
strain (D10). Bioassay-guided fractionation of the dichloromethane fraction of the dichloromethane/methanol extract yielded an active compound,
betulin, which exhibited good antiplasmodial activity with an IC50 value of 3.2 µg/ml. The reference compound, chloroquine gave an IC50 value
of 27.2 ng/ml. Two other compounds were also isolated from the dichloromethane extract namely, 7-hydroxy-6-methoxycoumarin and ent-kaur-
16-en-19-oic acid. These two compounds did not exhibit any significant antiplasmodial activity.
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Schefflera umbellifera is a semi-deciduous tree, widely dis-
tributed in Malawi, Mozambique and Zimbabwe as well as in
South Africa (Mbambezeli, 2006). This is the only South African
member of the genus which grows in warm, tropical regions and
is very closely related to Cussonia, even the Xhosa and Zulu
common names are the same. According to Palmer and Pitman
(1972), the specific epithet umbellifera refers to the umbellate
arrangement of the flowers. The genus Schefflera J.R.Forst. &
G.Forst. has about 650 species and was named in 1776 by G. and
J.R. Forster in honour of J.C. Scheffler of Danzig (Mbambezeli,
2006).
The leaves of S. umbellifera have been used traditionally to
treat rheumatism, colic and insanity and for malaria, a bark
extract is drunk (Watt and Breyer-Brandwijk, 1962). The
Vhavenda people use the roots of this plant as a diuretic and
laxative, for bathing, for weaning infants and for malaria,
venereal diseases and nausea (Hutchings et al., 1996). Accord-⁎ Corresponding authors.
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doi:10.1016/j.sajb.2009.07.019ing to Watt and Breyer-Brandwijk (1962) the bark is used for
stomach ulcers and magical purposes. In Tanzania, leaves are
used for indigestion while roots are used for fevers and venereal
disease, in emetics for nausea and in cold infusions for skin
irritation in new-born babies (Hutchings et al., 1996). Root bark
decoctions are administered for mental illness (Chhabra et al.,
1984). The secondary metabolite characteristic of the Araliaceae
family is triterpene glycosides, polyacetylenes, saponins
(Gunzinger et al., 1986) and caffeic acid derivatives (Li et al.,
2005). Limited information is known about the antimalarial
properties of S. umbellifera (Tetyana et al., 2002) and no
phytochemical studies of this plant have been reported. For this
study, three major compounds were isolated from the active
dichloromethane extract.
2. Materials and methods
2.1. Plant material
Plant material was collected at Mariepskop, Mpumalanga, on
the road towards the top above an electrical substation. This
area was a forest with a well-drained, rocky soil and humus clay.
A voucher specimen deposited at the South African National
Biodiversity Institute (SANBI) was identified as S. umbellifera
(Sond.) Baill.ts reserved.
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The wet leaves (6.00 kg) were dried in an oven at 60 °C for
overnight. 2.90 kg was recovered as a dry matter and finely
ground. 2.2 kg of the dried, ground leaves were extracted using
methanol/dichloromethane (1:1) for 12 h, filtered and reduced
to dryness using a rotovaporator. Methanol/dichloromethane
extract was then partitioned between hexane, dichloromethane
and water. The dichloromethane layer was dried and applied
to a silica column, chromatographed using silica gel (0.040–
0.063 mm), eluted with 5% acetone/hexane followed by 100%
acetone. This yielded eighteen fractions and some of these
fractions were later combined on the basis of their TLC profiles.
The first fraction (3.20 g) was further fractionated using flash
silica with 2% EtOAc/hexane as the mobile phase and afforded
a white pure compound 1 (23 mg, 0.72% yield). The second
fraction (0.66 g) was further fractionated on flash silica gel
using 40% EtOAc/hexane as the mobile phase and yielded a
pure white crystalline compound 3 (16 mg, 2.24% yield). The
third fraction (0.10 g) was also further chromatographed on
flash silica using 5% acetone/dichloromethane as mobile phase
and yielded a pure bright blue fluorescing compound 2 (6 mg,
6% yield).
The structures of all three compounds (Fig. 1) were deter-
mined using 1H NMR and 13C NMR data recorded on a Varian
400 MHz Unity spectrometer at the CSIR. All compounds were
dissolved in either deuterated chloroform or methanol and the
chemical shifts were recorded in ppm, tetramethylsilane (TMS)
was used as an internal standard and spectra were recorded at
room temperature. The mass spectral data were obtained from a
coupled HPLC-UV/MS instrument with a triple pole Quattro
LC Micro mass spectrometer which was set to operate both in
theESI− andESI+modes.High-resolutionmass spectra (HREIMS)
of compounds were obtained from the University of Witwaters-
rand using a VG 70SEQ HRMS instrument, operating mainly
on EI+ mode using 8 kV as standard ionization energy. A Perkin
Elmer 241 polarimeter at 589 nm using a sodium lamp as a lightFig. 1. Structures of compounds isolated from S. umbellifera.source and a cell with path length of 1 dm was used in all ex-
periments. These experiments were done using either methanol
or chloroform as solvent depending on the solubility of the com-
pound. Melting points were determined using a Reichert Koffler
hotstage apparatus and are uncorrected.
2.3. Description of the in vitro antimalarial assay
Compounds or extracts were assayed against Plasmodium
falciparum strain, namely chloroquine-sensitive (CQS) (D10).
Continuous in vitro cultures of asexual erythrocyte stages of
P. falciparum were maintained using the method of Trager and
Jensen (1976). The parasites were maintained at a 5% haema-
tocrit with RPMI 1640 (Biowhittaker) medium supplemented
withAlbumax II (lipid rich bovine albumin) (GibcoBRL) (25 g/l),
hypoxanthine (44 mg/l), HEPES [N-(2-hydroethyl)-piperazine-
N′-(2-ethansulfonic acid)] (Sigma Aldrich) (50 mg/l). The
cultures were incubated at 37 °C in an atmosphere of 93% N2,
4% CO2 and 3% O2.
Quantitative assessment of in vitro antiplasmodial activity
was determined via a parasite lactate dehydrogenase (pLDH)
assay (Makler et al., 1993). Chloroquine (CQ) was used as a ref-
erence drug in all experiments and the 50% inhibitory concentra-
tion (IC50) values were obtained using a non-linear dose-response
curve fitting analyses via Graph Pad Prism v.4.0 software.
3. Results and discussion
3.1. Identification and characterization of isolated compounds
Compound 1 was obtained as a white crystalline solid, crys-
tallized using an acetone/hexane solvent mixture. This com-
pound is not UV active but shows an intense pinkish colour
after spraying with vanillin on the TLC plate. The mass spec-
trum of compound 1 has an M+ peak at m/z 302.4011, which
corresponds to a molecular formula of C20H30O2 and some dis-
tinct fragment peaks at m/z 288 due to [M–CH2]
+, m/z 242
which corresponds to a loss of both a carboxyl and a methyl
group. After careful inspection of the NMR data the compound
was identified as ent-kaur-16-en-19-oic acid and the structure
confirmed by comparison of the 1H and 13C NMR data with
literature values (Buckingham, 1996; Lobitz et al., 1997).
Compound 2, was isolated as a pure bright blue fluorescing
powder. Electro-spray mass spectrometry data gave a molecular
ion signal M+ at m/z 192, corresponding to a molecular formula
of C10H8O4 and a distinct fragment peak at m/z 121 due to [M–
C3H2O2]
+. This compoundwas identified as 7-hydroxy-6-metho-
xycoumarin, also known as scopoletin. NMR data corresponded
with the reported data (Sun et al., 2006).
Compound 3 was obtained as a white crystalline solid using
flash chromatography and was crystallized from an ethyl ace-
tate/hexane mixture. This compound showed a very intense
pinkish colour upon spraying the TLC plate with vanillin. Com-
pound 3 was identified as betulin [lup-20(29)-en-3β,28-diol]
with a molecular formula of C30H50O2. The mass spectra also
showed very intense fragments at m/z 411 due to a [M–CH2
OH]+, m/z 426 due to [M–OH]+ and fragment peaks at m/z 235,
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lupine-type of compound with an angular hydroxyl methylene
group. NMR data of compound 3 compares very well with
authentic betulin (Mahato and Kunda, 1994; El Deeb et al.,
2003).
3.2. In vitro antimalarial activity of compounds isolated from
S. umbellifera
The dichloromethane/methanol extract of the leaves of
S. umbellifera exhibited good antimalarial activity (IC50
5.0 µg/ml) when tested against the chloroquine-susceptible
strain (D10). This extract was then partitioned between hexane,
dichloromethane and water and these fractions tested for
antimalarial activity. Only the dichloromethane fraction exhib-
ited potent antiplasmodial activity against the chloroquine-
sensitive strain (D10) with an IC50 of 3.7 µg/ml. This result is
regarded as potent based on the criteria set by the Novel Drug
Discovery Platform (NDDP) (potentb5 µg/ml; Clarkson et al.
(2004). The dichloromethane fraction was further fractionated
and because of limited plant material three major compounds
were targeted. From the three compounds isolated, only betulin
(compound 3) exhibited significant in vitro antimalarial activity
(3.2 µg/ml) against the P. falciparum chloroquine-susceptible
strain (D10). This activity compares well to that of the dichlo-
romethane fraction (Table 1) and therefore betulin can be con-
sidered as an active ingredient. Although isolation and biological
activity of betulin is well published, no information is known
regarding its isolation from S. umbellifera.
Although antimalarial activity of betulin has been reported,
limited information is known about the antimalarial activity of
S. umbellifera. According to Ziegler et al., 2004, betulin was iso-
lated from several plant families such as Rhamnaceae (Ziziphus
vulgaris) and Labiatae (Zataria multiflora) that have been tested
againstP. falciparum strains and showedmoderate activity (IC50b
12 µg/ml andb27 µM, respectively).
Badisa et al. (2002) and Henry et al. (2006) isolated betulin
from a Tanzanian plant, Uapaca nitida and reported it to be
inactive at 500 µg/ml. However, Monte et al. (1988), reported
betulin to inhibit P. falciparum strains with an IC50 of 12 µg/ml.
According to literature studies conducted, antiplasmodial acti-
vity of ent-kaur-16-en-19-oic acid has not been reported prev-
iously. It should also be noted that betulin does not exhibit
significant antimalarial activity except when it is converted into
betulinic acid. Antimalarial activity of betulinic acid againstTable 1
Antiplasmodial activity of the dichloromethane fraction of S. umbellifera,
ent-kaur-16-en-19-oic acid (1), scopoletin (2) and betulin (3) against
chloroquine-susceptible strain (D10).
Extract/compound Antiplasmodial activity, D10 IC50 (µg/ml)
CH2Cl2/MeOH extract 5.0
CH2Cl2 fraction 3.7
Compound 1 32.2
Compound 2 28.2
Compound 3 3.2
Chloroquine 27.2 ng/mlchloroquine-sensitive strains (T9-96) was reported to be
25.9 µg/ml whereas no activity was demonstrated by betulin
(500 µg/ml) (Yogeeswari and Sriram, 2005).
The results of this study confirms the traditional use of
the plant S. umbellifera and bioassay-guided fractionation of
the dichloromethane fraction of the dichloromethane/methanol
extract yielded an active compound, betulin, which exhibited
good antiplasmodial activity against the chloroquine-suscepti-
ble strain D10, with an IC50 value of 3.2 µg/ml. Considering that
a large percentage of South African plants have not been inves-
tigated chemically or pharmacologically, they remain a potential
source of leads for drug development.
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